- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00921011
Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
Iron and Atherosclerosis: Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
The study hypothesis (or theory) is that monthly loss of iron before menopause may reduce women's risk of hardening of the arteries, or atherosclerosis.
This study uses noninvasive, noncontrast magnetic resonance imaging (MRI) of arteries in women entering menopause. This will help to determine if there is a correlation between iron accumulation and hardening of the arteries. In addition, blood levels of hormones will be measured to help show differences due to hormone levels vs. iron accumulation.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State Univeristy Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- women at least 40 yrs of age
- between 1 and 6 menstrual cycles in the past 12 months
- 2 or more of the following risk factors: high blood pressure, diabetes, high cholesterol, smoking
- no known heart or vascular disease
Exclusion Criteria:
- any known cardiovascular disease such as coronary disease, peripheral vascular disease, heart failure
- contraindication to MRI scan (e.g. aneurysm clip, iron-containing metal)
NOTE that orthopedic hardware is usually MRI-compatible. We will go over detailed screening before enrollment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Perimenopausal women
Women at the beginning stages of menopause
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
vessel wall changes over time that precede plaque buildup
Time Frame: baseline, 1-year follow-up and 2-year follow-up
|
baseline, 1-year follow-up and 2-year follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
development of cardiovascular disease
Time Frame: annually for 4 years after baseline visit
|
annually for 4 years after baseline visit
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Subha V Raman, MD, Ohio State University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008H0308
- R01HL095563 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atherosclerosis
-
University Hospital, CaenUnknownPeripheral Arterial Disease | Atherosclerosis Obliterans | Atherosclerosis Right Leg | Atherosclerosis Left LegFrance
-
Nantes University HospitalAbbottCompletedAtherosclerosis ObliteransFrance
-
Central Hospital, Nancy, FranceSuspended
-
Federal University of São PauloCompletedAtherosclerosis of ArteryBrazil
-
MedtronicActive, not recruitingAtherosclerosis of Femoral Artery | Obstructive Disease | Atherosclerosis of Popliteal ArteryFrance
-
Cabinet de Medecine Interne Générale Demetrio PitarchCompletedAtherosclerosis of Artery
-
Emory UniversityThe Robert W. Woodruff FoundationCompleted
-
Korea UniversityMinistry of Health & Welfare, KoreaCompletedAtherosclerosis | Noninvasive Imaging of AtherosclerosisKorea, Republic of
-
Zhejiang Zylox Medical Device Co., Ltd.RecruitingAtherosclerosis of Femoral ArteryGermany
-
VA Office of Research and DevelopmentCompletedSaphenous Vein Graft AtherosclerosisUnited States